Novel bacteriophage therapy for treatment of left ventricular assist device infection

J Heart Lung Transplant. 2019 Apr;38(4):475-476. doi: 10.1016/j.healun.2019.01.001. Epub 2019 Jan 7.

Authors

Saima Aslam¹, Victor Pretorius², Susan M Lehman³, Sandra Morales³, Robert T Schooley¹

Affiliations

¹ Division of Infectious Diseases and Global Public Health, Department of Medicine, and University of California San Diego, La Jolla, California, USA.
² Division of Cardiovascular and Thoracic Surgery, Department of Surgery, University of California San Diego, La Jolla, California, USA.
³ Ampliphi Biosciences, Inc., San Diego, California, USA.

PMID: 30661974
DOI: 10.1016/j.healun.2019.01.001

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Heart-Assist Devices / adverse effects*
Humans
Male
Methicillin-Resistant Staphylococcus aureus*
Phage Therapy*
Prosthesis-Related Infections / etiology*
Prosthesis-Related Infections / therapy*
Staphylococcal Infections / etiology*
Staphylococcal Infections / therapy*
Staphylococcus epidermidis*